ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,365.96
0.16%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Kiromic BioPharma Inc (KRBP)

  7. Kiromic BioPharma Inc (KRBP) Noticias

KRBP

Kiromic BioPharma (KRBP)

Kiromic BioPharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KRBP
FechaHoraFuenteTítuloSímboloCompañía
19/09/202415:30Business WireKiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
19/09/202407:00Business WireKiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous RecommendationNASDAQ:KRBPKiromic BioPharma Inc
21/08/202415:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
14/08/202407:00Business WireKiromic BioPharma’s Deltacel Receives FDA Fast Track DesignationNASDAQ:KRBPKiromic BioPharma Inc
09/08/202414:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRBPKiromic BioPharma Inc
09/08/202407:00Business WireKiromic BioPharma Provides Update on Part 1 of the Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
01/08/202407:00Business WireKiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01NASDAQ:KRBPKiromic BioPharma Inc
18/07/202407:00Business WireKiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion PhaseNASDAQ:KRBPKiromic BioPharma Inc
28/06/202415:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
20/06/202407:00Business WireKiromic BioPharma Provides Updates on its Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
06/06/202407:00Business WireKiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
29/05/202407:00Business WireKiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
22/05/202416:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
20/05/202416:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:KRBPKiromic BioPharma Inc
20/05/202407:00Business WireKiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial SiteNASDAQ:KRBPKiromic BioPharma Inc
20/05/202405:29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:KRBPKiromic BioPharma Inc
17/05/202415:43Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KRBPKiromic BioPharma Inc
24/04/202407:08Business WireKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsNASDAQ:KRBPKiromic BioPharma Inc
10/04/202415:30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:KRBPKiromic BioPharma Inc
02/04/202407:18Business WireKiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
21/03/202416:21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:KRBPKiromic BioPharma Inc
19/03/202407:08Business WireEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
01/03/202407:08Business WireKiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
28/02/202417:30Business WireKiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7thNASDAQ:KRBPKiromic BioPharma Inc
14/02/202407:08Business WireResults from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsNASDAQ:KRBPKiromic BioPharma Inc
29/01/202406:47Business WireKiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
05/01/202407:08Business WireKiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
14/12/202307:17Business Wire Kiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
13/09/202315:35Business WireKiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14NASDAQ:KRBPKiromic BioPharma Inc
15/08/202315:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KRBPKiromic BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:KRBP

Su Consulta Reciente

NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
NYSE
BAC
Bank of America
NASDAQ
AMZN
Amazon.com
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados